Just months after gaining FDA approval, the drug nicknamed “female Viagra” has failed to come even remotely close to meeting sales expectations.
Addyi was developed to treat a condition known as hypoactive sexual desire disorder in women. Up to one-third of women in the United States are believed to suffer from some sort of the disorder which is only diagnosed when the lack of sexual desire actually causes stress in ...
continue reading...
The first drug to treat low sexual desire in women, touted as the “female Viagra,” won approval from the U.S. Food and Drug Administration. The health regulators approved the drug Addyi after twice rejecting the treatment because they did not think the benefits outweighed the drug’s risks, an article in Reuters reports.
Addyi is designed for women with a condition known as hypoactive sexual desire disorder. According to PubMed.gov, ...
continue reading...
